Brief: Aurobindo Pharma Says Tax Department Demands Recovery Of Refunds From Co
19/02/2026 09:46
Feb 19 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: TAX DEPARTMENT DEMANDS RECOVERY OF REFUNDS FROM AUROBINDO DISPUTED AMOUNT TOTALS 1.7 BILLION RUPEES Source text: ID:nNSE6RP0n1 Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11